Nicholson

Biography

Donald is the Chief Executive Officer and President of Enhance and has been leading the efforts of that company since February 2013, having previously been a non-executive director since 2009. Donald is a senior healthcare industry executive with over 24 years of experience in the pharmaceutical industry with Wellcome Plc, Boehringer Mannheim and as CFO of SkyePharma Plc. He is experienced in product and company acquisitions and disposals, in- and out-licensing arrangements, sale/royalty agreements and financial strategy and funding structures. His experience within this industry includes pharmaceuticals, biochemicals, orthopaedics, diagnostics and drug delivery, including dermatology. Donald is also the owner and Chief Executive Officer of Mercuriali, a specialty pharmaceutical company formed to provide strategic consulting advice and to seek development, acquisition and licensing opportunities within the healthcare sector both on behalf of associated companies and on its own account.

Research Interest

Integumen is a personal health company developing and commercialising technology and products for the human integumentary system that may improve physical appearance, hygiene and general health outcomes